financetom
Business
financetom
/
Business
/
Stellantis' $13 billion investment plan in US wins nod from investors, analysts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stellantis' $13 billion investment plan in US wins nod from investors, analysts
Oct 15, 2025 5:04 AM

(Reuters) -Stellantis' ( STLA ) new $13 billion investment plan in the U.S. marks a key step to countering tariffs imposed by President Donald Trump and to reviving the automakers' sales in its main market, investors and analysts said on Wednesday.

The plan, announced late on Tuesday, would help buffer the group from U.S. tariffs, an impact the French-Italian-American group had estimated in July at about $1.7 billion this year.

"This move is relevant and part of a wider path started by Stellantis ( STLA ) to be more and more aligned to the new business environment drawn by Trump with tariffs. It's paying off," Fabio Caldato, portfolio manager at AcomeA SGR told Reuters.

Caldato recently increased his exposure to Stellantis ( STLA ).

MORE FIRMS LIKELY TO MANUFACTURE IN U.S., ANALYST SAYS

In 2024, more than 40% of the 1.2 million vehicles Stellantis ( STLA ) sold in the U.S. were imports mostly from Mexico and Canada, on which Washington imposed tariffs of 25%.

"I see it as an irreversible trend, to manufacture more where sales happens, a sort of forced de-globalisation process," said Massimo Baggiani, founder at London-based Niche Asset Management, expecting more such announcements.

"More investments and sales in the U.S. might also attract more American investors in the long term," said Baggiani, who has sold Stellantis ( STLA ) shares in the past and was not investing back for now.

"Stellantis ( STLA ) shares remain cheap, but like the rest of the industry, they do not offer a significant discount compared to Ford or GM," he said.

Stellantis ( STLA ) shares rose as much as 4.3%, and up to Tuesday's close were down 33.5% year-to-date.

INVESTMENT PLAN TIMING SHOWS 'GREATER TARIFF COMFORT'

The investment plan was necessary "to mitigate the impact of US tariffs and relaunch brands that have lost significant volume in recent years," Equita analyst Martino De Ambroggi noted, adding the reshuffled spending "should result in limited changes to total capital expenditure."

"The timing of this announcement possibly signals greater tariff comfort/clarity on the part of Stellantis ( STLA ) management," TD Cowen analysts Itay Michaeli, Justin Barrell and Selina Liu, wrote in a note.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
DOJ Asks More Questions About Schlumberger-ChampionX Merger: Details
DOJ Asks More Questions About Schlumberger-ChampionX Merger: Details
Jul 3, 2024
Schlumberger Limited and ChampionX Corporation ( CHX ) received a second request from the United States Department of Justice regarding Schlumberger’s planned acquisition of ChampionX ( CHX ). SLB currently anticipates the transaction to conclude in late 2024 or early 2025, subject to regulatory approvals and customary closing conditions. The acquisition was approved by ChampionX ( CHX ) stockholders at...
US law firms smell opportunity as Supreme Court guts agency powers
US law firms smell opportunity as Supreme Court guts agency powers
Jul 3, 2024
(Reuters) - Law firms are capitalizing on client uncertainty sparked by a flurry of new U.S. Supreme Court rulings that favored opponents of federal agency powers, even as lawyers themselves differ on the decisions' immediate and long-term effects. Within hours of the decisions, major U.S. law firms began sending out client-focused emails and webinar invitations to discuss the cases and...
Blackstone to Sell Alinamin Pharmaceutical to MBK Partners
Blackstone to Sell Alinamin Pharmaceutical to MBK Partners
Jul 3, 2024
06:42 AM EDT, 07/03/2024 (MT Newswires) -- Blackstone (BX) said Wednesday it has agreed to sell Alinamin Pharmaceutical to Japanese private equity firm MBK Partners. No financial details were disclosed. But Reuters on Tuesday cited an unnamed source as saying the sale price for the Japanese supplement maker was 350 billion yen ($2.17 billion). Upon the closing of the deal,...
PwC names new China head amid regulatory scrutiny
PwC names new China head amid regulatory scrutiny
Jul 3, 2024
HONG KONG (Reuters) - PricewaterhouseCoopers (PwC) has named in-house executive Daniel Li as its new China head, a move that comes as it faces investigations by financial regulators in mainland China and Hong Kong. PwC said in a statement to Reuters on Wednesday that Shanghai-based Li assumed the role of chairman of PwC China and Asia Pacific with effect from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved